PL344534A1 - Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment - Google Patents

Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment

Info

Publication number
PL344534A1
PL344534A1 PL98344534A PL34453498A PL344534A1 PL 344534 A1 PL344534 A1 PL 344534A1 PL 98344534 A PL98344534 A PL 98344534A PL 34453498 A PL34453498 A PL 34453498A PL 344534 A1 PL344534 A1 PL 344534A1
Authority
PL
Poland
Prior art keywords
diagnosis
tools
recognized
treatment
rheumatoid arthritis
Prior art date
Application number
PL98344534A
Inventor
Lydie Meheus
Ann Union
Joseph Raymackers
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98870078A external-priority patent/EP0949270A1/en
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of PL344534A1 publication Critical patent/PL344534A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
PL98344534A 1997-11-28 1998-11-30 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment PL344534A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97870195 1997-11-28
EP98870078A EP0949270A1 (en) 1998-04-09 1998-04-09 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
PCT/EP1998/007714 WO1999028344A2 (en) 1997-11-28 1998-11-30 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment

Publications (1)

Publication Number Publication Date
PL344534A1 true PL344534A1 (en) 2001-11-05

Family

ID=26148315

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98344534A PL344534A1 (en) 1997-11-28 1998-11-30 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment

Country Status (8)

Country Link
EP (1) EP1034186A2 (en)
JP (1) JP2002512939A (en)
AU (1) AU2155899A (en)
CA (1) CA2309534A1 (en)
CZ (1) CZ20001963A3 (en)
HU (1) HUP0004338A2 (en)
PL (1) PL344534A1 (en)
WO (1) WO1999028344A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7184426B2 (en) 2002-12-12 2007-02-27 Qualcomm, Incorporated Method and apparatus for burst pilot for a time division multiplex system
FR2773078B1 (en) * 1997-12-30 2000-05-26 Univ Toulouse USE OF CITRULLIN PEPTIDES DERIVED FROM FILAGGRIN FOR THE TREATMENT OF RHUMATOID POLYARTHRITIS
WO2001046222A2 (en) * 1999-12-21 2001-06-28 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
FR2826124B1 (en) * 2001-06-13 2004-01-02 Bio Merieux METHOD FOR THE DETECTION OF RHUMATOID POLYARTHRITIS SPECIFIC SELF-ANTIBODIES
NL1019540C2 (en) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Method for detecting autoantibodies from patients suffering from rheumatoid arthritis, peptide and assay kit.
AU2004260961B2 (en) 2003-07-29 2010-05-20 Abbott Laboratories Gmbh Analytical method for pancreatin and comparable compositions
AT413768B (en) * 2003-07-29 2006-05-15 Herkner Kurt Dipl Ing Dr Techn BIOCHEMICAL DIAGNOSTIC TO DETECT RHEUMATOID ARTHRITIS
ES2297521T3 (en) * 2003-12-23 2008-05-01 F. Hoffmann-La Roche Ag METHOD FOR EVALUATING RHEUMATOID ARTHRITIS BY MEASURING ANTI-PCC AND INTERLEUQUINE 6.
EP1980855A1 (en) 2004-02-27 2008-10-15 Roche Diagnostics GmbH Method of assessing rheumatoid arthritis by measuring anti-CCP and serum amyloid A
WO2007014896A1 (en) 2005-07-29 2007-02-08 Solvay Pharmaceuticals Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
GB0525492D0 (en) * 2005-12-15 2006-01-25 Univ Dundee Filaggrin
FR2900657B1 (en) * 2006-05-03 2009-04-17 Univ Toulouse IDENTIFICATION OF MACROPHAGE ACTIVATION MODULATORS, USEFUL FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2074428B1 (en) 2006-09-29 2015-07-01 Roche Diagnostics GmbH Assessing the risk of disease progression for a patient with rheumatoid arthritis
EP2229402B1 (en) * 2007-12-03 2012-08-08 SQI Diagnostics Systems Inc. Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies
PL2294086T3 (en) 2008-06-04 2018-02-28 Modiquest B.V. Anti-inflammatory agents
NZ608489A (en) * 2009-03-30 2014-08-29 Nestec Sa Citrullinated peptides for diagnosing and prognosing rheumatiod arthritis
EP2325195A1 (en) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Viral citrullinated peptides and uses thereof
EP2336769A1 (en) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Trigger assay for differentiating between rheumatic and non-rheumatic disorders
EP2402368A1 (en) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Histone citrullinated peptides and uses thereof
EP2527841A1 (en) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Methods for the diagnosis of rheumatoid arthritis
JP6040228B2 (en) * 2011-05-27 2016-12-07 ノルディック・ビオサイエンス・エー／エスＮｏｒｄｉｃ Ｂｉｏｓｃｉｅｎｃｅ Ａ／Ｓ Detection of diagnostic peptides
US9322822B2 (en) * 2011-08-12 2016-04-26 Hiroshima University Method for detecting asbestos
MD20140054A2 (en) 2011-12-16 2014-10-31 Olema Pharmaceuticals, Inc. Novel benzopyran compounds, compositions and uses thereof
WO2014141244A1 (en) * 2013-03-12 2014-09-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Synthetic peptides for the treatment of autoimmune diseases
EP3024849A2 (en) 2013-07-24 2016-06-01 Vilara AB Novel antibodies for the diagnosis and treatment of rheumatoid arthritis
KR101634958B1 (en) * 2014-06-13 2016-06-30 한국생명공학연구원 probes, kits and methods for detecting mutation of filaggrin gene
EP3056903A1 (en) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-Casp8
EP3056904A1 (en) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Method of assessing rheumatoid arthritis by measuring anti-CCP and anti-MCM3
WO2016128348A1 (en) 2015-02-13 2016-08-18 F. Hoffmann-La Roche Ag Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd
CN111007262A (en) * 2019-12-25 2020-04-14 漳州卫生职业学院 Kit for auxiliary diagnosis of RA and detection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660994A (en) * 1986-11-10 1997-08-26 Progen Biotechnik Gmbh Method of detecting tissue-specific, insoluble cytoskeletal proteins
WO1992019649A1 (en) * 1991-04-26 1992-11-12 Clonatec Antigens recognized by antibodies of rhumatoid polyarthritis, and preparation and use thereof
FR2752842B1 (en) * 1996-08-30 1998-11-06 Biomerieux Sa ANTIGENS DERIVED FROM FILAGGRINS AND THEIR USE FOR THE DIAGNOSIS OF RHUMATOID POLYARTHRITIS
NL1004539C2 (en) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide derived from an antigen recognized by autoantibodies of patients with rheumatoid arthritis, antibody to it and method for detecting autoimmune antibodies.

Also Published As

Publication number Publication date
HUP0004338A2 (en) 2001-02-28
WO1999028344A2 (en) 1999-06-10
CZ20001963A3 (en) 2002-04-17
JP2002512939A (en) 2002-05-08
EP1034186A2 (en) 2000-09-13
WO1999028344A3 (en) 1999-08-12
AU2155899A (en) 1999-06-16
CA2309534A1 (en) 1999-06-10

Similar Documents

Publication Publication Date Title
PL344534A1 (en) Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
EG21902A (en) Containers
EP0742793A4 (en) Bcl-2-associated proteins
HK1011747A1 (en) Toner bottle
GB9309142D0 (en) Laparoscopic instrument
GB9506962D0 (en) Containers
GB9412166D0 (en) Retargetting antibodies
GB9312578D0 (en) Determining gas concentration
GB9314802D0 (en) Modified proteins
EP0731164A4 (en) HUMAN PHOSPHOLIPASE C-alpha AND DNA SEQUENCE CODING FOR THE SAME
HUP0103605A3 (en) Resilient containers for hyperpolarized gases
GB2301055B (en) Containers
GB9320046D0 (en) Container testing
GB9608887D0 (en) Tool container
ZA982338B (en) Method for the diagnosis of rheumatoid arthritis
EP0682117A4 (en) Dna coding for carbonic anhydrase
GB2305906B (en) Containers
GB9410050D0 (en) Receptacle
GB2305415B (en) Containers
GB2302948B (en) Analyser for liquids
AU124488S (en) Toner bottle
CA76773S (en) Toner bottle
GB9511037D0 (en) Tool container
GB9307535D0 (en) Container for cosmetics
TW296794U (en) Lens-type compass